Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Mortality Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Mortality Among Patients With Immune-Mediated Inflammatory Disease and COVID-19'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology